CYAD - セリアド （Celyad SA）

Celyad Oncology (CYAD) is delisting its American Depositary Shares (ADSs) from Nasdaq. Read more here

Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO ) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy of its drug candidate LP-10 for hemorrhagic cystitis. PureCycle Technologies, Inc. (NASDAQ: PCT ) rose 31.8% to $6.29 after the company issued Q4 update. ThermoGenesis Holdings, Inc. (NASDAQ: THMO ) shares jumped 30.7% to $5.48. ThermoGenesis shares jumped around 99% on Wednesday after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies. Science 37 Holdings, Inc. (NASDAQ: SNCE ) gained 27.1% to $0.3083. EverCommerce Inc. (NASDAQ: EVCM ) jumped 21.2% to $10.86 following Q4 results. Wejo Group Limited (NASDAQ: WEJO ) gained 17.7% to $0.4001. Verde Clean Fuels, Inc. (NASDAQ: VGAS ) jumped 17.1% to $9.25. Celyad Oncology SA (NASDAQ: CYAD ) gained 16.1% to $0.9599. Celyad Oncology booked €35.1 million in goodwill and intangible impairment in FY22.

Celyad Oncology (CYAD) said it will recognize a non-cash impairment of its goodwill and intangible oncology assets and that its board plans to submit for a vote its business plan…

Regulatory News: Celyad Oncology (Euronext & Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (the “Company”), a biotechnology company focused on the discovery and development of innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, today announced a non-cash impairment of its goodwill and intangible oncology assets. This impairment comes as a result of

Gainers Ibio Inc (NYSE: IBIO ) shares rose 97% to $1.4787 after the company announced MUC16 as its latest immune-oncology target program. Universal Security Instruments, Inc. (NYSE: UUU ) rose 40.6% to $3.09 after the company reported a year-over-year increase in Q3 EPS and revenues. SciSparc Ltd. (NASDAQ: SPRC ) gained 25.4% to $1.1410 after the company announced its MitoCareX Bio joint venture achieved achieved its first milestone pursuant to the March 10, 2022 Founders and Investment Agreement. Cyclo Therapeutics, Inc. (NASDAQ: CYTH ) surged 22.4% to $1.3952. AMC Networks Inc. (NASDAQ: AMCX ) shares jumped 20.9% to $24.60 after reporting better-than-expected Q4 results. EBET, Inc. (NASDAQ: EBET ) gained 18.4% to $0.6321 following strong Q4 results and guidance from DraftKings. Apexigen, Inc. (NASDAQ: APGN ) jumped 15.8% to $1.10. Telephone and Data Systems, Inc. (NYSE: TDS ) rose 15% to $12.80 after the company posted Q4 results and increased its common share dividend from $0.18 to $0.185.

Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO ) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy of its drug candidate LP-10 for hemorrhagic cystitis. PureCycle Technologies, Inc. (NASDAQ: PCT ) rose 31.8% to $6.29 after the company issued Q4 update. ThermoGenesis Holdings, Inc. (NASDAQ: THMO ) shares jumped 30.7% to $5.48. ThermoGenesis shares jumped around 99% on Wednesday after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies. Science 37 Holdings, Inc. (NASDAQ: SNCE ) gained 27.1% to $0.3083. EverCommerce Inc. (NASDAQ: EVCM ) jumped 21.2% to $10.86 following Q4 results. Wejo Group Limited (NASDAQ: WEJO ) gained 17.7% to $0.4001. Verde Clean Fuels, Inc. (NASDAQ: VGAS ) jumped 17.1% to $9.25. Celyad Oncology SA (NASDAQ: CYAD ) gained 16.1% to $0.9599. Celyad Oncology booked €35.1 million in goodwill and intangible impairment in FY22.

Celyad Oncology (CYAD) said it will recognize a non-cash impairment of its goodwill and intangible oncology assets and that its board plans to submit for a vote its business plan…

Regulatory News: Celyad Oncology (Euronext & Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (the “Company”), a biotechnology company focused on the discovery and development of innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, today announced a non-cash impairment of its goodwill and intangible oncology assets. This impairment comes as a result of

Gainers Ibio Inc (NYSE: IBIO ) shares rose 97% to $1.4787 after the company announced MUC16 as its latest immune-oncology target program. Universal Security Instruments, Inc. (NYSE: UUU ) rose 40.6% to $3.09 after the company reported a year-over-year increase in Q3 EPS and revenues. SciSparc Ltd. (NASDAQ: SPRC ) gained 25.4% to $1.1410 after the company announced its MitoCareX Bio joint venture achieved achieved its first milestone pursuant to the March 10, 2022 Founders and Investment Agreement. Cyclo Therapeutics, Inc. (NASDAQ: CYTH ) surged 22.4% to $1.3952. AMC Networks Inc. (NASDAQ: AMCX ) shares jumped 20.9% to $24.60 after reporting better-than-expected Q4 results. EBET, Inc. (NASDAQ: EBET ) gained 18.4% to $0.6321 following strong Q4 results and guidance from DraftKings. Apexigen, Inc. (NASDAQ: APGN ) jumped 15.8% to $1.10. Telephone and Data Systems, Inc. (NYSE: TDS ) rose 15% to $12.80 after the company posted Q4 results and increased its common share dividend from $0.18 to $0.185.

Cyclo Therapeutics (CYTH) +19%. Celyad Oncology (CYAD) +16%. VolitionRx VNRX -12%. Applied Therapeutics (APLT) -11%.

Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO ) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy of its drug candidate LP-10 for hemorrhagic cystitis. PureCycle Technologies, Inc. (NASDAQ: PCT ) rose 31.8% to $6.29 after the company issued Q4 update. ThermoGenesis Holdings, Inc. (NASDAQ: THMO ) shares jumped 30.7% to $5.48. ThermoGenesis shares jumped around 99% on Wednesday after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies. Science 37 Holdings, Inc. (NASDAQ: SNCE ) gained 27.1% to $0.3083. EverCommerce Inc. (NASDAQ: EVCM ) jumped 21.2% to $10.86 following Q4 results. Wejo Group Limited (NASDAQ: WEJO ) gained 17.7% to $0.4001. Verde Clean Fuels, Inc. (NASDAQ: VGAS ) jumped 17.1% to $9.25. Celyad Oncology SA (NASDAQ: CYAD ) gained 16.1% to $0.9599. Celyad Oncology booked €35.1 million in goodwill and intangible impairment in FY22.

Celyad Oncology (CYAD) said it will recognize a non-cash impairment of its goodwill and intangible oncology assets and that its board plans to submit for a vote its business plan…

Regulatory News: Celyad Oncology (Euronext & Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (the “Company”), a biotechnology company focused on the discovery and development of innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, today announced a non-cash impairment of its goodwill and intangible oncology assets. This impairment comes as a result of

Gainers Ibio Inc (NYSE: IBIO ) shares rose 97% to $1.4787 after the company announced MUC16 as its latest immune-oncology target program. Universal Security Instruments, Inc. (NYSE: UUU ) rose 40.6% to $3.09 after the company reported a year-over-year increase in Q3 EPS and revenues. SciSparc Ltd. (NASDAQ: SPRC ) gained 25.4% to $1.1410 after the company announced its MitoCareX Bio joint venture achieved achieved its first milestone pursuant to the March 10, 2022 Founders and Investment Agreement. Cyclo Therapeutics, Inc. (NASDAQ: CYTH ) surged 22.4% to $1.3952. AMC Networks Inc. (NASDAQ: AMCX ) shares jumped 20.9% to $24.60 after reporting better-than-expected Q4 results. EBET, Inc. (NASDAQ: EBET ) gained 18.4% to $0.6321 following strong Q4 results and guidance from DraftKings. Apexigen, Inc. (NASDAQ: APGN ) jumped 15.8% to $1.10. Telephone and Data Systems, Inc. (NYSE: TDS ) rose 15% to $12.80 after the company posted Q4 results and increased its common share dividend from $0.18 to $0.185.

Cyclo Therapeutics (CYTH) +19%. Celyad Oncology (CYAD) +16%. VolitionRx VNRX -12%. Applied Therapeutics (APLT) -11%.